Baseline | Follow-up-1 | Follow-up-2 | |||
---|---|---|---|---|---|
MMAS-8n (%) | Pharmacist consultation n=11 | Standard care n=10 | Pharmacist consultation n=11 | Standard care n=10 | Pharmacist consultation, persistence 4 weeks later n=11 |
Low (<6) | 3 (27) | 1 (10) | 1 (9) | 1 (10) | 1 (9) |
Medium (6–8) | 3 (27) | 1 (10) | 4 (36) | 2 (20) | 4 (36) |
High (8) | 5 (45) | 8 (80) | 6 (55) | 7 (70) | 6 (55) |
BMQ-specific mean (SD) | |||||
Necessity | 18 (5) | 21 (3) | 21 (4) | 21 (3) | 20 (3) |
Concern | 16 (4) | 10 (4) | 12 (6) | 10 (5) | 13 (7) |
Necessity-concerns differential | 3 (8) | 11 (6) | 9 (8) | 11 (5) | 7 (9) |
Proportion expressing concern>necessityn (%) | 3 (27) | 0 (0) | 0 (0) | 0 (0) | 1 (9) |
Use of the MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from Donald E Morisky, ScD, ScM, MSPH, Professor, Department of Community Health Sciences, UCLA School of Public Health, 650 Charles E Young Drive South, Los Angeles, CA 90095–1772, USA.
MMAS, Morisky Medication Adherence Scale.